Trang chủ
Tài liệu nghiên cứu Y học
Search Journal
Search Article
Search by Auth
Category
All Category
Biomedicine
Biochem,Gene&Molecular Biology
Computer Science
Public Health
Medicine & Public Health
Medicine Public Health
Immunology and Microbiology
From
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
To
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
European Journal of Cancer
Last issue
All issues
All articles
Search
Volume 120, Pages 1-140 (October 2019)
Previous vol/issue
Next vol/issue
1. Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies
Download PDF
Tác giả
Pauline Corbaux, Mévidette El-Madani, Michel Tod, Julien Péron, Benoit You.
2. Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer
Download PDF
Tác giả
Xavier Pivot, Mark Pegram, Javier Cortes, Diana Lüftner, Chul Kim.
3. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial
Download PDF
Tác giả
Mark Robson, Kathryn J. Ruddy, Seock-Ah IM, Elżbieta Senkus, Pierfranco Conte.
4. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion
Download PDF
Tác giả
Ana Lluch, Ana M. González-Angulo, David Casadevall, Agda K. Eterovic, Joan Albanell.
5. Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer
Download PDF
Tác giả
Caroline Truntzer, Nicolas Isambert, Laurent Arnould, Sylvain Ladoire, Francois Ghiringhelli.
6. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation
Download PDF
Tác giả
Ping Yuan, Sha Huang, Fei-Chao Bao, Jin-Lin Cao, Jian Hu.
7. The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy
Download PDF
Tác giả
Siow Ming Lee, Sunil Upadhyay, Conrad Lewanski, Stephen Falk, Allan Hackshaw.
8. Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
Download PDF
Tác giả
E.E.C. de Jong, K.J.C. Sanders, T.M. Deist, W. van Elmpt, P. Lambin.
9. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker
Download PDF
Tác giả
Heejung Chae, Deokhoon Kim, Changhoon Yoo, Kyu-pyo Kim, Baek-Yeol Ryoo.
10. Superior skin cancer classification by the combination of human and artificial intelligence
Download PDF
Tác giả
Achim Hekler, Jochen S. Utikal, Alexander H. Enk, Axel Hauschild, Alexander Thiem.
11. Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study
Download PDF
Tác giả
Peter Hohenberger, Sylvie Bonvalot, Frits van Coevorden, Pjotr Rutkowski, Paolo Casali.
12. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Download PDF
Tác giả
Robin L. Jones, Mark J. Ratain, Peter J. O'Dwyer, Lillian L. Siu, Gary Schwartz.
13. Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trial
Download PDF
Tác giả
Rosanna K. Jackson, Martina Liebich, Philip Berry, Julie Errington, Gareth J. Veal.
14. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing
Download PDF
Tác giả
Hong Sook Kim, Hongui Cha, Jinho Kim, Woong-Yang Park, Se-Hoon Lee.
15. Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study
Download PDF
Tác giả
Jair Bar, Gal Markel, Teodor Gottfried, Ruth Percik, Amir Onn.